FP staff04 Aug 2022 14:19:53 IST
The Nothing Company, led by Carl Pei, has launched its first mobile device, the No Phone (1). Months before the actual launch of the smartphone, there was a lot of hype around the device.
The device was launched in India starting at Rs 32,999. While there have been some issues related to the delivery of the device and the Nothing Phone itself (1), it’s safe to say that it was, on the whole, well received by most tech enthusiasts. So much so that people have wanted a lighter version and a cheaper version of the Nothing Phone (1).
As a result, a rumor began that Nothing would soon make Nothing Phone (1) Lite, a barebones version of Nothing Phone (1) that would have no glyphs and would be ready for a Diwali launch in India. year.
The rumor also claimed that the “Lite” phone in the works will be offered at an affordable price with a starting price of ₹ 24,999. Another feature that would have been removed was wireless charging.
Glyph interface and wireless charging were the two features that were the most popular for Nothing Phone (1) and separated the device from the rest of the field.
The rumor also added that the “Lite” version would keep the rest of the specs, such as the display, processor and cameras. The battery has been reported to receive an update. It had to be powered by a 5,000mAh battery.
Carl Pei took to Twitter to silence all speculation and revealed that all the rumors about Nothing Phone (1) Lite were actually fake news and that they had no intention of designing or producing one.
Fake News https://t.co/7Au5UP1FEW
– Carl Pei (@getpeid) August 4, 2022
Typically, tech companies, especially smartphone makers, don’t respond to rumors or suggestions on social media, regardless of whether they are true or false. However, Carl Pei had to make this announcement and categorically deny the existence of Nothing Phone (1) Lite.
It makes sense for Pei to go out and deny the rumors as a device with such a huge price difference has the potential to seriously dent Nothing Phone’s current sales (1).